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Linear scleroderma is a subgroup of circumscribed
scleroderma lesions.1 The involvement of other organs
in this type of scleroderma is rare. Although there are
various treatments for this disease, such as oral and to-
pical corticosteroids, methotrexate, topical vitamin D,
photochemotherapy [psoralen and UVA light (PUVA)
therapy], and UVA1 phototherapy,2,3 the lesions are
often refractory and can cause scar formation and con-
tracture. Among the phototherapy modality, UVA1
phototherapy is highly effective for stabilizing cir-
cumscribed scleroderma.4 Once the lesion is stable,
additional surgical treatment may be useful for linear
scleroderma. Lesions on the face or head may cause
cosmetic disfigurement, which are a major concern
especially for younger patients. We report a case of
linear scleroderma that was successfully treated with
surgery.
CASE PRESENTATION
A 29-year-old Japanese woman presented with alope-
cia lesions in the occipital region. She had bronchial
asthma and her sister had been diagnosed as alopecia
areata. Two years before, the patient initially presented
with an itchy sensation localized to the occipital region.
She consulted local dermatologists and was diagnosed
as contact dermatitis. Topical steroid ointment applied
to the lesion was not effective. She then consulted
another hospital due to the concomitant existence of
alopecia lesions. Based on the clinical appearance, lin-
ear scleroderma was suspected. Although super-potent
steroids were applied for approximately 1 year, the
lesion enlarged and extended to the frontal area with
hair loss. Topical PUVA therapy was initiated and 
30 sessions were applied without efficacy. The patient
was then referred to our university hospital.
She presented with a 6×3 cm brownish linear
plaque in the occipital region with sclerosis and hair
loss (Figure 1). She did not have Raynaud’s phenom-
enon, dysphagia, or other manifestations of systemic
sclerosis. Anti-scl-70 antibody, centromere antibody,
and other anti-nuclear antibodies were all negative.
Urine and serum calcium and phosphate levels were
within normal limits. We continued to treat her with
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narrow-band UVB, which had been used for 2 years.
Narrow-band UVB was preferably used at that time
because of a major concern for photo-carcinogenesis
of topical PUVA. The lesion remained stable during
this period. A surgical approach was then used to
treat the lesion. The lesion was resected with a 5-mm
margin and deep to the trapezius fascia.
Pathologic analysis revealed thickened and swollen
collagen fibers and shrinking organelles (Figure 2).
Denatured collagen fibers and lymphoid infiltration
without calcium deposits were observed (Figure 2).
Based on the clinical and pathologic findings, linear
scleroderma was diagnosed. The resection was success-
ful without recurrence for at least 1 year (Figure 3).
DISCUSSION
Linear scleroderma is a form of circumscribed sclero-
derma reported by Addison in 1854.5 Fox reported that
this disease improves with convalescence.6 Generally,
the circumscribed lesion enlarges linearly with areas
of hyperpigmentation on the face, head, and extremi-
ties. Zulian et al reported 750 juveniles with localized
scleroderma,7 among which 12% of the patients had 
a positive family history for rheumatic or autoimmune
disease and 13.3% of patients experienced a possible
environmental trigger. The lesions of linear sclero-
derma can appear almost anywhere on the body. Severe
conditions, such as severe wrist contracture, orbital
involvement, and hair loss have been reported.2,8,9
Over two-thirds of linear scleroderma patients are
positive for antinuclear antibody.10 A specific type of
linear scleroderma, Sclérodermie en coup saber, often
results in hair loss and lagophthalmos. Although this
lesion is not progressive, it is a cosmetic concern.
Topical, intralesional, and oral steroids are used for
treatment. In severe cases, immunosuppression with
methotrexate may be used. Recently, topical vitamin D
analogues have been used successfully.3 There has also
been increasing interest in the benefit of PUVA therapy
and UVA1 therapy.11 We previously reported the ben-
efits of topical PUVA therapy for systemic sclerosis.12
Figure 1. The alopecia lesion in her occipital region upon initial
presentation to our hospital.
Figure 2. Photomicrograph of a skin biopsy obtained at our hos-
pital. Denatured collagen fibers and lymphoid infiltration with-
out calcium deposits were observed. Based on the clinical and
pathologic findings, she was diagnosed with linear scleroderma
(hematoxylin and eosin stain).
Figure 3. One year after surgery, a scar is observed in the occipi-
tal region, but no new lesions are present.
Therapeutic effectiveness was evidenced by clinical
improvement and concomitant changes in the histo-
logic, laboratory, and thermographic parameters. UVA1
radiation phototherapy is also effective for treating
systemic sclerosis.13 The underlying mechanism of
the efficacy of UVA1 is likely to be the depletion of
skin-infiltrating T cells by UVA-1-induced T cell apop-
tosis and upregulation of matrix metalloproteinase-1
(collagenase-1) expression in dermal fibroblasts.14
Histologic evaluation of skin specimens obtained be-
fore and after UVA-1 phototherapy revealed loosen-
ing of the collagen bundles and the appearance of
small collagen fibers. In the present patient, topical
PUVA and narrow-band UVB, unfortunately, were
not effective for refractory lesion and hair loss.
Conservative treatments, including topical therapy,
photochemotherapy, and immunosuppression can re-
sult in scar formation. Therefore, surgical treatment is
sometimes required. In progressive cases, lesions may
extend to the muscle or bone, and therefore care must
be taken during surgery. The timing of the surgery,
depth evaluation, and rebuilding methods must also
be taken into account when considering the option of
surgery. Magnetic resonance imaging is useful for
evaluating the extent of the disease.15 Various surgi-
cal methods can be used, such as a skin flap, fat graft,
dermofat graft, and bone graft.1 In the present case,
we were able to restructure the lesion site with a sim-
ple suture, but a large lesion localized on the head or
face may require a flap or tissue expander for recon-
struction. Currently, there is no established treatment
for cases of enlarged deformities of the face or move-
ment disorders. Alternative treatments for these types
of lesions must be considered first. For example, in
the present case, we observed the patient for 2 years
in an outpatient department before deciding to per-
form surgery. In general, surgical treatment should not
be considered until the lesion has stopped expanding.
In this patient, the resection was successful without
recurrence for 1 year. Further consideration is required,
however, for actively spreading lesions. We presented
with this case since the surgical resection was success-
ful to treat stable lesions of linear scleroderma in terms
of cosmetic outcome. Since the timing of resection
has not been well examined, the accumulation of this
type of case reports may change a treatment modality
for linear scleroderma.
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